Triochem Products Reports Profit Driven by Asset Monetization, Eyes Trading Future

Triochem Products Ltd. has announced a profit of ₹7.97 crore for the financial year ending March 31, 2026. This positive bottom line was significantly influenced by an exceptional gain of ₹11.17 crore resulting from the sale of immovable properties, plant, and machinery. The company also reported nil revenue from operations, as manufacturing activities have ceased.

Reader Takeaway: Asset sale boosts profit; future hinges on new trading venture's success.

What just happened

For the financial year 2025-26, Triochem Products reported a profit of ₹7.97 crore, a notable turnaround from a loss of ₹0.40 crore in the previous year. This profit includes an exceptional gain of ₹11.17 crore from the sale of its immovable properties, plant, and machinery, which were divested in three tranches between January and February 2026. The company's revenue from operations was nil, indicating a complete cessation of its manufacturing activities. Total income for the year stood at ₹0.86 crore.

The company has also confirmed it is a zero-debt entity, with no outstanding borrowings. Basic Earnings Per Share (EPS) stood at ₹325.34 for FY26, compared to ₹(16.33) in FY25.

Why this matters

This filing marks a significant strategic shift for Triochem Products. The cessation of manufacturing, which management attributes to post-Covid challenges impacting its business model, and the pivot to trading activities represent a new direction. The substantial gain from asset sales provides the company with a cash surplus and a debt-free status, which are crucial for funding this transition and exploring new ventures.

The backstory

Triochem Products previously operated with manufacturing activities. However, the business model requiring personal presentation and relationship building faced severe challenges after the Covid-19 pandemic, leading management to deem its revival unlikely in the near future. Consequently, the decision was made to pivot towards trading activities.

What changes now

The company is now focused on developing its trading business. Management anticipates that trading activities will help stabilize performance by the end of FY 2026-27. The proceeds from asset sales are expected to be allocated towards these new business endeavors.

Risks to watch

The primary risk lies in the success of the business pivot to trading activities. With manufacturing operations fully ceased, the company's future performance is entirely dependent on the stability and growth of its new trading venture. Additionally, management has identified a prolonged recession as a potential macro risk that could impact future operations.

Peer comparison

Information on direct peers in the trading sector or companies undergoing similar business pivots is not available in the filing.

Context metrics (time-bound)

• Financial Year 2025-26:
  • Profit: ₹7.97 crore
  • Exceptional Gain (Asset Sale): ₹11.17 crore
  • Revenue from Operations: ₹0 crore
  • Total Income: ₹0.86 crore
  • Basic EPS: ₹325.34
  • Debt Position: Zero Debt
• Financial Year 2024-25:
  • Profit/Loss: ₹(0.40) crore
  • Basic EPS: ₹(16.33)

What to track next

Investors should closely monitor the company's progress in establishing and scaling its trading business, the effective allocation of proceeds from asset sales, and any updates on the stabilization of trading income in the upcoming fiscal year.